Skip to main navigation Skip to search Skip to main content

Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project

  • Paul L. Hess
  • , Kevin Kennedy
  • , Michael Cowherd
  • , Salim S. Virani
  • , Frederick A. Masoudi
  • , Ann Marie Navar
  • , Robert W. Yeh
  • , P. Michael Ho
  • , Thomas M. Maddox

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)151-152
Number of pages2
JournalAmerican heart journal
Volume195
DOIs
StatePublished - Jan 2018

Cite this